Skip to main content
. 2020 Jul 28;12(8):2082. doi: 10.3390/cancers12082082

Figure 3.

Figure 3

Overall survival of KDM6A high-EZH2 low vs. KDM6A low-EZH2 group. (a) A KM plot, showing overall survival of KDM6A high EZH2 low vs. KDM6A low EZH2 group, KDM6A high EZH2 high vs. KDM6A high EZH2 low group, KDM6A low EZH2 high vs. KDM6A low EZH2 low group, and KDM6A high EZH2 high vs. KDM6A low E2H2 low. SKCM patients were stratified based on the median expression of KDM6A and EZH2. (b,c) Overall survival based on sex and EZH2-KDM6A median expression. p < 0.05 indicates the significance of survival.